8-K: Selectis Health CEO, CFO Resigns; Interim Appointed

Selectis Health, Inc. announced the resignation of CEO and CFO Adam Desmond, appointing Krystal Eckhart as interim CEO and CFO.

Summary

• Adam Desmond has resigned from all positions at Selectis Health, Inc., including CEO, CFO, and Board Member, effective May 14, 2026.
• Krystal Eckhart has been appointed as the Interim CEO and CFO, effective May 15, 2026.
• Ms. Eckhart has over 15 years of experience in healthcare revenue cycle and financial operations, and has been with the Company since 2016.
• She previously served as Vice President of Revenue Management and Director of Accounts Receivable for the Company.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative event due to the unexpected departure of key leadership, though the appointment of an experienced interim mitigates immediate concerns.

Positives

• Appointment of an experienced interim CEO and CFO with extensive knowledge of the company's operations.
• Krystal Eckhart has over 15 years of relevant experience in healthcare finance and operations.
• Ms. Eckhart has been with Selectis Health since 2016, indicating continuity and familiarity with the business.

Negatives

• Sudden departure of the CEO and CFO, Adam Desmond, which could create uncertainty.
• The need for an interim appointment suggests a lack of immediate succession planning for these key roles.

Risks

• Potential disruption to operations and strategic direction due to the sudden change in leadership.
• Uncertainty regarding the reasons for Adam Desmond's resignation and the terms of his separation agreement.
• The interim nature of the new appointments may lead to a period of instability until permanent leadership is established.

Future Outlook

No specific future outlook or guidance was provided in this filing, which solely reports on leadership changes.

Management Comments

• Adam Desmond and the Board of Directors agreed that he would resign all positions with the Company.
• Krystal Eckhart was appointed to serve as the Company's Interim CEO and CFO.

Industry Context

StockSavvy.ai notes that leadership changes, particularly at the CEO and CFO level, are common in the healthcare sector, often driven by performance, strategic shifts, or regulatory pressures. The appointment of an internal candidate like Ms. Eckhart can signal a desire for continuity during a transition period.

Management Changes

Stakeholder Impact

• Shareholders: Potential short-term uncertainty due to leadership change, but continuity provided by interim appointment.
• Employees: May experience uncertainty regarding future leadership and strategic direction.
• Creditors/Suppliers: No immediate impact indicated, but long-term stability depends on effective leadership.

Next Steps

• The company will operate under interim leadership while likely searching for permanent CEO and CFO appointments.
• Review of the Separation Agreement and Release between the Company and Adam Desmond.

Key Dates

Recommendation

The filing indicates a significant leadership change with the resignation of the CEO and CFO. While an experienced interim has been appointed, the uncertainty surrounding the reasons for the departure and the search for permanent leadership warrants a 'hold' recommendation until more clarity on the company's future direction is available.

Keywords

Selectis Health, CEO resignation, CFO resignation, Interim CEO, Interim CFO, Corporate Governance, Leadership Change, 8-K Filing